Search hospitals > Colorado > Aurora
Barbara Davis Center for Childhood Diabetes
Claim this profileAurora, Colorado 80045
Global Leader in Type 1 Diabetes
Global Leader in Diabetes
Conducts research for Low Blood Sugar
Conducts research for Type 2 Diabetes
Conducts research for High Cholesterol
113 reported clinical trials
12 medical researchers
Summary
Barbara Davis Center for Childhood Diabetes is a medical facility located in Aurora, Colorado. This center is recognized for care of Type 1 Diabetes, Diabetes, Low Blood Sugar, Type 2 Diabetes, High Cholesterol and other specialties. Barbara Davis Center for Childhood Diabetes is involved with conducting 113 clinical trials across 23 conditions. There are 12 research doctors associated with this hospital, such as Andrea Steck, MD, Peter Gottlieb, MD, Robert Slover, MD, and Sarit Polsky, MD.Area of expertise
1Type 1 Diabetes
Global LeaderIA-2 positive
ZnT8 positive
Stage 2
2Diabetes
Global LeaderIA-2 positive
ZnT8 positive
Stage 2
Top PIs
Andrea Steck, MDBarbara Davis Center at University of Colorado Anschutz Medical Campus3 years of reported clinical research
Studies Type 1 Diabetes
Studies Diabetes
5 reported clinical trials
7 drugs studied
Peter Gottlieb, MDUniversity of Colorado School of Medicine: Barbara Davis Center for Diabetes3 years of reported clinical research
Studies Diabetes
Studies Type 1 Diabetes
4 reported clinical trials
4 drugs studied
Robert Slover, MDBarbara Davis Center / Pediatric7 years of reported clinical research
Studies Type 1 Diabetes
Studies Diabetes
3 reported clinical trials
7 drugs studied
Sarit Polsky, MDBarbara Davis Center / University of Colorado Denver3 years of reported clinical research
Studies Diabetes
Studies Chronic Kidney Failure
2 reported clinical trials
2 drugs studied
Clinical Trials running at Barbara Davis Center for Childhood Diabetes
Type 1 Diabetes
Diabetes
Dermatomyositis
Myositis
Inflammatory Myositis
Extended Wear Insulin Infusion Set
for Type 1 Diabetes
This trial is testing a new device called the Extended Wear Infusion Set (EWIS) that helps deliver insulin for a longer period. It is aimed at adults with Type 1 diabetes who use an insulin pump. The device could make managing diabetes easier by reducing how often they need to change their infusion set. The Extended Wear Infusion Set (EWIS) is designed to improve convenience and quality of life for insulin pump users by allowing longer use compared to the standard duration.
Recruiting1 award N/A
Hybrid Closed Loop System
for Type 1 Diabetes
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Recruiting1 award N/A17 criteria
Fully Closed Loop System
for Type 1 Diabetes
Protocol Overview/Synopsis This study will be conducted at 3 sites, with each site performing a session with up to 6 participants with a lower HbA1c (\<8.0%) in one of 3 age categories (26-60, 18-25, or 14-17 years) followed by a session of up to 6 additional participants with a higher HbA1c (8.0-12.0%) with the same age categories (26-60, 18-25, or 14-17 years). The trial will aim to complete a total of 36 participants: 12 total participants within each age category and 18 participants within each HbA1c category; 12 participants at each site. The study may enroll up to 70 participants to account for dropouts across the study. The study will be performed for 5 days and 4 nights at a local hotel/rental. Following the hotel session, participants will undergo a 7 day/6-night remote monitored at-home use session. The study will also conduct a two-week control period gathering data on glycemic control and insulin administration with the participants usual care therapy. Participants will be randomized 1:1, stratified by age cohort, to either group A (control period prior to AIDANET use) or group B (control period after AIDANET use).
Recruiting1 award N/A17 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Barbara Davis Center for Childhood Diabetes?
Barbara Davis Center for Childhood Diabetes is a medical facility located in Aurora, Colorado. This center is recognized for care of Type 1 Diabetes, Diabetes, Low Blood Sugar, Type 2 Diabetes, High Cholesterol and other specialties. Barbara Davis Center for Childhood Diabetes is involved with conducting 113 clinical trials across 23 conditions. There are 12 research doctors associated with this hospital, such as Andrea Steck, MD, Peter Gottlieb, MD, Robert Slover, MD, and Sarit Polsky, MD.